CHINA MEDICAL UNIVERSITY
Patent Owner
Stats
- 52 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Mar 01, 2018 most recent publication
Details
- 52 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 332 Total Citation Count
- Aug 08, 2003 Earliest Filing
- 49 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9744146 Method for alleviating disturbance of bile acid metabolism, amino acid metabolism, and/or gut microbiota metabolismOct 31, 14Aug 29, 17[A61K, A23L]
9708310 Phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof, preparation method and use thereofFeb 04, 16Jul 18, 17[C07D]
9550983 Nucleic acid sequence segment for enhancing protein expressionAug 07, 15Jan 24, 17[C12N, G01N]
9410969 Method for determining and treating amyotrophic lateral sclerosisSep 15, 15Aug 09, 16[A61K, G01N, A61P, C07K]
9360451 Method for diagnosing whether a subject is at high risk for developing atherosclerotic vascular diseaseFeb 22, 13Jun 07, 16[G01N]
9320774 Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancerApr 25, 14Apr 26, 16[A61K, B82Y, A61P, A61N]
9266813 Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereofMar 28, 14Feb 23, 16[A61K, A01N, C07D, C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0020,924 MESENCHYMAL STEM CELL, METHOD FOR CLONOGENIC EXPANSION THEREOF, METHOD FOR ISOLATING THEREOF, AND USE THEREOFAbandonedNov 06, 15Jan 26, 17[A61K, C12N, G01N]
2016/0362,463 Pharmaceutical composition inhibiting interaction between MZF-1 and Elk-1AbandonedJun 15, 15Dec 15, 16[C07K]
2016/0067,221 USE OF ERGOTHIONEINE FOR INDUCING ACTIVITY OF NRF2 IN CELLAbandonedSep 04, 15Mar 10, 16[A61K]
2016/0051,620 Methods for regulating transcription of multiple genes and expression of multiple targetsAbandonedJul 02, 15Feb 25, 16[A61K]
2015/0037,399 NOVEL USE OF PIPOXOLAN AND ITS PHARMACEUTICAL COMPOSITIONAbandonedMay 02, 14Feb 05, 15[A61K]
2015/0003,713 METHOD FOR ANALYZING TISSUE CELLS USING HYPERSPECTRAL IMAGINGAbandonedMay 09, 14Jan 01, 15[G06K]
2014/0377,542 PLATE WITH TITANIUM DIOXIDE ON ITS SURFACE, MANUFACTURING PROCESS AND USES THEREOFAbandonedSep 12, 13Dec 25, 14[B05D, C07K]
2014/0288,055 COMPOSITIONS AND METHODS FOR DIAGNOSIS OF SCHIZOPHRENIAAbandonedApr 09, 14Sep 25, 14[C12Q, G01N]
2014/0273,032 COMPOSITIONS AND METHODS FOR DIAGNOSIS OF SCHIZOPHRENIAAbandonedApr 09, 14Sep 18, 14[G01N]
2014/0193,463 PEPTIDE FOR INHIBITING DIPEPTIDYL-PEPTIDASE IVAbandonedJan 04, 13Jul 10, 14[C12N, C07K]
2014/0171,413 COMPOSITIONS AND METHODS FOR DIAGNOSIS OF SCHIZOPHRENIAAbandonedDec 13, 12Jun 19, 14[G01N]
2014/0127,723 METHOD FOR DETERMINING RISK OF AMYOTROPHIC LATERAL SCLEROSISAbandonedJan 03, 14May 08, 14[G01N]
2014/0065,612 METHOD FOR IN VITRO DETECTING KERATIN GENE FUSION OF SQUAMOUS-CELL CANCERAbandonedMar 05, 13Mar 06, 14[C12Q]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.